Funding

Centauri Therapeutics

United Kingdom · Biotech · Healthtech

Develops immunotherapeutic treatments for antimicrobial infections

Visit centauritherapeutics.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series A+£6MAMR Action Fund — Role not disclosed

Investors

AMR Action FundSeries A+

Coverage

Feb 24, 2026Centauri Therapeutics · Series A+

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourcescentauritherapeutics.com ↗